Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols

Protocols

EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.

Contents

Title Abstract Investigator
Prostate Upgrading Team Project Thompson, Ian M.
Prostate-Specific Glycoproteins for Early Detection of Prostate Cancer Zhang, Hui L.
Protein profiling for detection of high risk breast cancer Semmes, John
Proteomic Approach for Diagnostic Applications in Head and Neck Cancer To evaluate the test characteristics of a panel of biomarkers for identifying patients with early stage head and neck squamous cell carcinoma (HNSCC). The ... Tainsky, Michael A.
Proteomic Data Resources for EDRN Ovary Cancer Researchers within the EDRN This project will generate a highly valuable data resource and make it available to all EDRN ovarian cancer researchers. The resource will include ... McIntosh, Martin
Proteomic Genetic and Longitudinal Pathways to Ovarian Cancer Biomarkers Discovery and verification of early detection ovarian cancer plasma/serum biomarkers. Skates, Steven
Proteomic Profiling of Serum and Other Body Fluids for the Early Detection of Colon Cancers Semmes, John
Proteomics Biomarker Development Laboratory The Biomarker Development Laboratory is focused on the application of a proteomic approach for the development of cancer biomarkers. The laboratory will apply ... Not listed
Protocol for Comparing Promoter Hypermethylation Methods in NSCLC Tockman, Melvyn S.
Recurrent Genomic Gains in Preinvasive Lesions as a Biomarker of Risk for Lung Cancer Lung carcinoma development is accompanied by field changes that may have diagnostic significance. We have previously shown the importance of chromosomal ... Garcia, Marileila Varella
Release of Set Aside Funds - microRNA Biomarkers for Renal Cell Carcinoma Thompson, Ian M.
Research Depository of Normal and Neoplastic Human Tissues Gazdar, Adi
S-adenosylmethionine as a biomarker for the early detection of lung cancer BACKGROUND: S-Adenosylmethionine (AdoMet) is a major methyl donor for transmethylation reactions and propylamine donor for the biosynthesis of polyamines in ... Greenberg, Alissa K.
SELDI Phase I: Assay Validation-Prostate It is then the goal of this collaborative project – EDRN-Prostate-SELDI Investigational Collaboration (EPSIC) - to use state-of-the-art protein profiling ... Semmes, John
SELDI Profiling of serum and urine from patients with urologic disease in support of bladder cancer studies Semmes, John
SELDI Validation Study Phase II This project –A Comprehensive Program for the Validation of Prostate Cancer Early Detection with Novel Protein Identification Techniques -- is divided into ... Semmes, John
SELDI and LC-MS/MS discovery and profiling study of hepatocarcinomas Semmes, John
SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BACKGROUND: This study aimed to show that SHOX2 DNA methylation is a tumor marker in patients with suspected lung cancer by using bronchial fluid aspirated ... Schmidt, Bernd
SPORE/EDRN/PRE-PLCO Ovarian Phase II Validation Study Phase II specimens from 160 ovarian cancer cases and 640 benign disease or general population controls were assembled from four Early Detection Research ... Cramer, Daniel
San Antonio Center of Biomarkers of Risk for Prostate Cancer (SABOR) To determine if there are ways to predict which men will get prostate cancer, if there are ways to predict how a prostate cancer will develop (for example, ... Thompson, Ian M.
Screen Detection of Mismatch Repair Deficient Colorectal Neoplasias Using a Stool Based DNA Analysis Lynch, Henry
Seattle Area Hormone and Reproductive Epidemiology Breast Cancer Study The SHARE Study (Seattle Area Hormone And Reproductive Epidemiology Breast Cancer Study) is a five-year, population-based case-control study, funded by the ... Li, Christopher
Soluble Mesothelin Related Peptide (SMRP) and Osteopontin (OPN) as Early Detection Markers for Malignant Mesothelioma (MM) Phase I: - Identification and assemblage of representative cohorts of individuals with MM, no malignancies but increased risk for MM due to asbestos exposure, ... Pass, Harvey Ira
Spectral Markers for Early Detection of Colon Neoplasia Roy, Hemant K.
Standard Specimen Reference Set: Breast The primary objective of this study is to assemble a well-characterized set of blood specimens to test biomarkers that, in conjunction with mammography, can ... Marks, Jeffrey
Standard Specimen Reference Set: Liver Utilize the remaining specimens collected under the DCP protocol to develop and validate markers for the early detection of HCC Volk, Michael L.
Standard Specimen Reference Set: Lung The NCI/EDRN/SPORE Lung Cancer Biomarkers Group (LCBG) began its activities back in November 2004 and developed clear objectives and strategies on how to begin ... Bigbee, William L.
Standard Specimen Reference Set: Pancreatic The primary objective of the EDRN Pancreatic Cancer Working Group Proposal is to create a reference set consisting of well-characterized serum/plasma specimens ... Brand, Randall E.
Standard Specimen Reference Set: Prostate To collect biologic samples on men prior to prostate biopsy, in association with clinical information and common data elements appropriate for evaluation of ... Sanda, Martin
Standard Specimen Reference Set: Colon The Early Detection Research Network, Great Lakes-New England Clinical, Epidemiological and Validation Center (GLNE CVC) announces the availability of serum, ... Brenner, Dean
Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.

Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html